Long-term Audiometric Outcomes in Unilateral... (2019 study) Skip to main content
Study J Int Adv Otol 2019

Long-term Audiometric Outcomes in Unilateral Sudden Sensorineural Hearing Loss without Recurrence

Pecorari G, Riva G, Naqe N, Bruno G, Nardo M, Albera R, J Int Adv Otol, 2019

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers followed 50 patients with sudden hearing loss in one ear to see how their hearing changed over several years after treatment with intravenous corticosteroids.

What They Found

This observational study followed patients for a mean of 5.26 plus or minus 2.28 years and found that hearing in the affected ear stayed stable for most patients, while the unaffected ear tended to worsen over time. Of the patients evaluated, 54% showed no change in hearing over time, 26% showed worsening, and 20% showed improvement. Hearing changes were correlated with alcohol consumption and the presence of vasculopathies. On average, hearing at low frequencies improved over time.

What This Means for Canadian Patients

This abstract does not mention hyperbaric oxygen therapy, so it does not address HBOT. It does suggest that after sudden hearing loss without recurrence, the affected ear's hearing tends to remain stable long-term, while patients who drink alcohol or have vasculopathies (blood vessel disease) face a higher risk of their hearing worsening over time.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

The study is observational with no control group and does not report statistical tests confirming that alcohol consumption or vasculopathies directly cause hearing changes, so these associations should not be read as proven cause-and-effect relationships.

This plain-language summary was generated with AI assistance from the study's abstract; it has not been individually reviewed by a clinician. Always consult the source study and a qualified healthcare professional. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Study
Category Sudden Hearing Loss
Source Pubmed
PubMed ID 31058596
Year Published 2019
Journal J Int Adv Otol
MeSH Terms Administration, Intravenous; Adrenal Cortex Hormones; Adult; Aged; Alcohol Drinking; Audiometry, Pure-Tone; Auditory Threshold; Female; Follow-Up Studies; Hearing; Hearing Loss, Sensorineural; Hearing Loss, Sudden; Humans; Hyperbaric Oxygenation; Male; Middle Aged; Retrospective Studies; Risk Factors; Vascular Diseases

Cite This Study

Share

This study relates to Sudden Sensorineural Hearing Loss. Read the full clinical overview, the evidence base, and Canadian treatment access for this condition.

Find a Canadian Clinic Treating Sudden Hearing Loss

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last updated: March 19, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology